Morbidity and mortality due to Plasmodium vivax malaria in Papua, Indonesia and its control using antimalarial drugs
<p>Plasmodium vivax malaria threatens nearly half the world’s population. This relapsing disease may be more severe than previously recognised and is proving refractory to current malaria control measures. This thesis aimed to describe the burden of anaemia and mortality attributable to vivax...
Main Author: | Douglas, N |
---|---|
Other Authors: | Price, R |
Format: | Thesis |
Language: | English |
Published: |
2011
|
Subjects: |
Similar Items
-
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
by: Borrmann, S, et al.
Published: (2008) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
by: Kloprogge, F
Published: (2013) -
Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
by: Amin, A, et al.
Published: (2005) -
Standardizing estimates of the Plasmodium falciparum parasite rate
by: Smith, D, et al.
Published: (2007) -
Plasmodium infection and its risk factors in eastern Uganda
by: Pullan, R, et al.
Published: (2010)